SCHEMBL30009269

SCHEMBL30009269

O=C(c1ccncc1)c1cc2c(ccc3ccccc32)[nH]1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.62
LMNA P02545 2/20 0.62
KDM4E B2RXH2 1/20 0.62
HSD17B10 Q99714 1/20 0.62
MAP2K1 Q02750 1/20 0.49
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
FLT3 P36888 4/20 0.44
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
CLK1 P49759 1/20 0.42
DYRK1A Q13627 1/20 0.42
MAPT P10636 3/20 0.41
CYP1A1 P04798 1/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2302776 1.00 ALDH1A1 (0.62) ALDH1A1LMNAKDM4EHSD17B10MAP2K1
SCHEMBL12428146 0.88 HSD17B10 (0.74) ALDH1A1LMNAKDM4EHSD17B10MAP2K1
SCHEMBL30533222 0.85 MAP2K1 (0.70) ALDH1A1LMNAKDM4EHSD17B10MAP2K1
SCHEMBL14739587 0.85 MAP2K1 (0.70) ALDH1A1LMNAKDM4EHSD17B10MAP2K1
SCHEMBL29403077 0.84 ALDH1A1 (0.73) ALDH1A1LMNAKDM4EHSD17B10MEN1
SCHEMBL14739175 0.84 KDM4E (0.64) ALDH1A1LMNAKDM4EHSD17B10MEN1
SCHEMBL14740027 0.84 ALDH1A1 (0.73) ALDH1A1LMNAKDM4EHSD17B10MEN1
SCHEMBL30116222 0.84 KDM4E (0.64) ALDH1A1LMNAKDM4EHSD17B10MEN1
SCHEMBL2302082 0.83 ALDH1A1 (0.62) ALDH1A1LMNAKDM4EHSD17B10MEN1
SCHEMBL29403397 0.83 ALDH1A1 (0.62) ALDH1A1LMNAKDM4EHSD17B10MAP2K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4340835-A1 METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE METANOIA BIO INC. (US) 2024-03-27 EP disclosed
EP-4340896-A1 METHODS AND COMPOSITIONS FOR TREATING OCULAR NEOVASCULAR DISEASE METANOIA BIO INC. (US) 2024-03-27 EP disclosed
EP-4340836-A1 METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL CONDITIONS METANOIA BIO INC. (US) 2024-03-27 EP disclosed
CN-116615241-A Methods and compositions for diabetes treatment and beta cell regeneration 加利福尼亚大学董事会 2023-08-18 CN disclosed
WO-2022245711-A1 METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL CONDITIONS METANOIA BIO INC. (US) 2022-11-24 WO disclosed
WO-2022245697-A1 METHODS AND COMPOSITIONS FOR TREATING OCULAR NEOVASCULAR DISEASE METANOIA BIO INC. (US) 2022-11-24 WO disclosed
WO-2022245702-A1 METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE METANOIA BIO INC. (US) 2022-11-24 WO disclosed